A Phase II Study of Weekly Docetaxel-Cisplatin As First-Line Treatment for Advanced Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

A Phase II Study of Weekly Docetaxel-Cisplatin As First-Line Treatment for Advanced Non-small Cell Lung Cancer

Published:2009-09 Issue:9 Volume:4 Page:1144-1147
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Binder Daniel,Hackenthal Matthias,Graseck Lutz,Schweisfurth Hans,Schäper Christoph,Krüll Matthias,Temmesfeld-Wollbrück Bettina,Suttorp Norbert,Beinert Thomas,Hellriegel Klaus-Peter

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference12 articles.

1. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

2. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer;Scagliotti;J Clin Oncol,2002

3. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group;Fossella;J Clin Oncol,2003

4. Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: a randomized, multicenter phase III trial;Georgoulias;J Clin Oncol,2004

5. Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients;Ohe;Jpn J Clin Oncol,2001

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: A cost-effectiveness analysis;Oral Oncology;2019-06

2. Docetaxel versus docetaxel plus cisplatin for non-small-cell lung cancer: a meta-analysis of randomized clinical trials;Oncotarget;2017-04-13

3. Evaluation of contemporary platinum-doublet chemotherapy-modified dose and schedules;Lung Cancer Management;2013-10

4. A Prospective Phase II Trial of Induction Chemotherapy with Docetaxel/Cisplatin for Masaoka Stage III/IV thymic Epithelial Tumors;Journal of Thoracic Oncology;2013-07